Wilcock GK - Search Results

1

Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.

Roberts CJ, Ford JM, Truman CA, Scott M, Mäkelä PM, Wilcock GK. Roberts CJ, et al. Among authors: wilcock gk. Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):721-4. doi: 10.1007/s002280050541. Eur J Clin Pharmacol. 1998. PMID: 9923574 Clinical Trial.

2

Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease.

Ford JM, Truman CA, Wilcock GK, Roberts CJ. Ford JM, et al. Among authors: wilcock gk. Clin Pharmacol Ther. 1993 Jun;53(6):691-5. doi: 10.1038/clpt.1993.91. Clin Pharmacol Ther. 1993. PMID: 8513661 Clinical Trial.

3

Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.

MacGowan SH, Wilcock GK, Scott M. MacGowan SH, et al. Among authors: wilcock gk. Int J Geriatr Psychiatry. 1998 Sep;13(9):625-30. doi: 10.1002/(sici)1099-1166(199809)13:9<625::aid-gps835>3.0.co;2-2. Int J Geriatr Psychiatry. 1998. PMID: 9777427 Clinical Trial.

4

Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.

Forsyth DR, Wilcock GK, Morgan RA, Truman CA, Ford JM, Roberts CJ. Forsyth DR, et al. Among authors: wilcock gk. Clin Pharmacol Ther. 1989 Dec;46(6):634-41. doi: 10.1038/clpt.1989.199. Clin Pharmacol Ther. 1989. PMID: 2598567

5

Determination of tacrine hydrochloride in human serum by chloroform extraction, reversed-phase high-performance liquid chromatography and fluorimetric detection.

Forsyth DR, Ford JM, Truman CA, Roberts CJ, Wilcock GK. Forsyth DR, et al. Among authors: wilcock gk. J Chromatogr. 1988 Dec 9;433:352-8. doi: 10.1016/s0378-4347(00)80620-9. J Chromatogr. 1988. PMID: 3235566 No abstract available.

6

An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.

Wilcock GK, Surmon DJ, Scott M, Boyle M, Mulligan K, Neubauer KA, O'Neill D, Royston VH. Wilcock GK, et al. Age Ageing. 1993 Sep;22(5):316-24. doi: 10.1093/ageing/22.5.316. Age Ageing. 1993. PMID: 8237620

7

Tacrine for senile dementia of Alzheimer's or Lewy body type.

Wilcock GK, Scott MI. Wilcock GK, et al. Lancet. 1994 Aug 20;344(8921):544. doi: 10.1016/s0140-6736(94)91933-x. Lancet. 1994. PMID: 7914636 No abstract available.

8

The diagnosis of vascular dementia in the light of the new criteria.

Amar K, Wilcock GK, Scott M. Amar K, et al. Among authors: wilcock gk. Age Ageing. 1996 Jan;25(1):51-5. doi: 10.1093/ageing/25.1.51. Age Ageing. 1996. PMID: 8670529

9

The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type.

Amar K, Bucks RS, Lewis T, Scott M, Wilcock GK. Amar K, et al. Among authors: wilcock gk. Age Ageing. 1996 Nov;25(6):443-8. doi: 10.1093/ageing/25.6.443. Age Ageing. 1996. PMID: 9003880

10

Long-term use of tacrine.

Wilcock GK, Scott M, Pearsall T. Wilcock GK, et al. Lancet. 1994 Jan 29;343(8892):294. doi: 10.1016/s0140-6736(94)91140-1. Lancet. 1994. PMID: 7905118 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters